KORU Medical Systems, Inc. (KRMD)

Market Cap	268.67M
Revenue (ttm)	39.07M
Net Income (ttm)	-3.71M
Shares Out	46.32M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	504,316
Open	5.19
Previous Close	5.25
Day's Range	5.17 - 5.88
52-Week Range	1.86 - 5.88
Beta	0.62
Analysts	Strong Buy
Price Target	4.83 (-16.72%)
Earnings Date	Nov 12, 2025

About KRMD

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 80
• Stock Exchange: NASDAQ
• Ticker Symbol: KRMD
• Website: https://www.korumedical.com

Financial Performance

In 2024, KORU Medical Systems's revenue was $33.65 million, an increase of 17.98% compared to the previous year's $28.52 million. Losses were -$6.07 million, -55.85% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for KRMD stock is "Strong Buy." The 12-month stock price target is $4.83, which is a decrease of -16.72% from the latest price.

Price Target

$4.83

(-16.72% downside)

Analyst Consensus: Strong Buy